Selinexor Enhances Natural Killer Cell Function Against Multiple Myeloma Cells

被引：0
|
作者：
Fisher, Jack G. [1 ]
Doyle, Amber D. P. [1 ]
Graham, Lara V. [1 ]
Forconi, Francesco [2 ]
Cragg, Mark S. [3 ,4 ]
Walker, Christopher J. [5 ]
Khakoo, Salim I. [1 ]
Blunt, Matthew D. [1 ]
机构：
[1] Univ Southampton, Sch Clin & Expt Sci, Fac Med, Southampton, Hants, England
[2] Univ Southampton, Sch Canc Sci, Fac Med, Southampton, Hants, England
[3] Univ Southampton, Antibody & Vaccine Grp, Ctr Canc Immunol, Southampton, Hants, England
[4] Univ Southampton, Antibody & Vaccine Grp, Ctr Canc Immunol, Fac Med, Southampton, Hants, England
[5] Karyopharm Therapeut, Newton, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179744
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
    Davies, FE
    Raje, N
    Hideshima, T
    Lentzsch, S
    Young, G
    Tai, YT
    Lin, B
    Podar, K
    Gupta, D
    Chauhan, D
    Treon, SP
    Richardson, PG
    Schlossman, RL
    Morgan, GJ
    Muller, GW
    Stirling, DI
    Anderson, KC
    BLOOD, 2001, 98 (01) : 210 - 216
  • [42] NATURAL-KILLER CELL-ACTIVITY IN PATIENTS WITH MULTIPLE-MYELOMA
    OGMUNDSDOTTIR, HM
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 133 - 143
  • [43] MULTIPLE-MYELOMA WITH COEXPRESSION OF MYELOID AND NATURAL-KILLER-CELL ANTIGENS
    DRACH, J
    GATTRINGER, C
    HUBER, H
    BLOOD, 1990, 76 (01) : 265 - 266
  • [44] Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy
    Chan, A. C.
    Neeson, P.
    Leeansyah, E.
    Tainton, K.
    Quach, H.
    Prince, H. M.
    Harrison, S. J.
    Godfrey, D. I.
    Ritchie, D.
    Berzins, S. P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (01): : 49 - 58
  • [45] Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia
    Yun, Hyun Don
    Schirm, Dawn K.
    Felices, Martin
    Miller, Jeffrey S.
    Eckfeldt, Craig E.
    BLOOD ADVANCES, 2019, 3 (16) : 2448 - 2452
  • [46] Overcoming barriers to the natural killer cell response against multiple myeloma: Manipulating the NKG2A/HLA-E checkpoint and CAR engineering of memory-like natural killer cells
    Zhou, Alice Y.
    Berrien-Elliott, Melissa M.
    Vij, Ravi
    Fiala, Mark
    Becker-Hapak, Michelle
    Marsala, Lynne
    Jacobs, Miriam T.
    Marin, Nancy D.
    Tran, Jennifer
    Foltz, Jennifer
    Wong, Pamela
    Fortier, Julie
    Kelley, Sarah
    Neal, Carly
    Russler-Germain, David
    Schappe, Timothy
    Fehniger, Todd A.
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Novel monoclonal antibody that enhances natural killer (NK) cell cytotoxicity against multiple myeloma (MM): Preclinical data and interim phase I clinical trial results
    Benson, D. M., Jr.
    Romagne, F.
    Squiban, P.
    Wagtmann, N.
    Farag, S.
    Mita, A.
    Hofmeister, C.
    Smith, M.
    Bakan, C.
    Caligiuri, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Multiple Myeloma Cells Modulate ICAM-3 To Evade Natural Killer Cell-Mediated Lysis
    Garg, Tarun K.
    Edmondson, Ricky D.
    Chavan, Shweta S.
    Khan, Junaid
    Szmania, Susann
    Stivers, Justin
    Macleod, Veronica
    Stone, Katie
    Woods, Emily
    Johann, Donald
    Barlogie, Bart
    Epstein, Joshua
    van Rhee, Frits
    BLOOD, 2013, 122 (21)
  • [49] Secreted β3-Integrin Enhances Natural Killer Cell Activity against Acute Myeloid Leukemia Cells
    Skaik, Younis
    Vahlsing, Stefanie
    Goudeva, Lilia
    Eiz-Vesper, Britta
    Battermann, Anja
    Blasczyk, Rainer
    Figueiredo, Constanca
    PLOS ONE, 2014, 9 (06):
  • [50] Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
    Swift, Brenna E.
    Williams, Brent A.
    Kosaka, Yoko
    Wang, Xing-Hua
    Medin, Jeffrey A.
    Viswanathan, Sowmya
    Martinez-Lopez, Joaquin
    Keating, Armand
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07): : 1020 - 1028
12345